Loading...

H. Lundbeck A/S

HLBBFā€¢PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$7.16
$0.51(7.67%)
U.S. Market opens in 7h 38m

H. Lundbeck A/S (HLBBF) Stock Overview

Explore H. Lundbeck A/Sā€™s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.7B
P/E Ratio14.22
EPS (TTM)$0.51
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$5.46
3 Months$7.05
1 Year Target$7.23

HLBBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of H. Lundbeck A/S (HLBBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.11, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $7.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.22 and a market capitalization of 5.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.67%
5-Day Change
3.77%
1-Month Change
21.36%
3-Month Change
17.38%
6-Month Change
4.53%
Year-to-Date (YTD) Change
4.37%
1-Year Change
40.39%
3-Year Change
39.03%
5-Year Change
51.37%
All-Time (Max) Change
51.37%

Contact Information

https://www.lundbeck.com
45 36 30 13 11
Ottiliavej 9, Valby, NaN, 2500

Company Facts

57,070 Employees
IPO DateJul 13, 2022
CountryDK
Actively Trading

Frequently Asked Questions